Meridian Clinical Research, a leading investigative research network, is seeking participants for COVID-19 vaccine studies in Dakota Dunes, SD, and Norfolk, NE. The Phase III clinical trials will help determine the safety and efficacy of investigational vaccines intended to protect against SARS-Cov-2, the coronavirus that causes COVID-19.
- To be eligible, participants must be 19 or older. Participants will receive study-related exams, and an investigational COVID-19 vaccine or placebo at no cost. As part of these studies, Meridian is also seeking people who meet one of the following criteria…
- People who may be in close, regular contact with infected persons; this may include, but is not limited to essential workers, healthcare workers, first responders, manufacturing/factory workers, teachers, transit workers, etc.
- People with underlying health conditions, such as high blood pressure, diabetes, obesity,
asthma, etc. - Healthy individuals age 19+ with no known history of COVID-19 infection
- People age 65+
Beau Garland, the company’s vice president for advancement, spoke on KLIN’s Road to Recovery and described more of the process.
UNL Police Chief Hassan Ramzah, Nebraska Vaccine Trial, Daily News https://t.co/ykYmAhcj1R
— 1400 KLIN (@KLINRadio) July 16, 2020
Eligible participants will receive compensation for participating and do not need health insurance to join. People interested in joining a study can sign up for more information at mcrmed.com/covid-19-vaccine-study or call the Meridian call center at (402) 934-7563. Meridian has enrolled more than 42,000 patients into clinical trials since 1999, and is a leading investigative site network for vaccine trials. In 2015, the company supported studies for the Ebola vaccine when the outbreak occurred, and conducted research for Zika virus and anthrax vaccines in the past year.
- Meridian will remain fully-staffed and operational through the COVID-19 pandemic, and is working to meet or exceed all federal and state safety guidelines at its sites nationwide. Meridian is seeking participants for COVID-19 vaccine studies in the following locations:
- Georgia (Savannah): Meridian Clinical Research, 340 Eisenhower Dr #1200, Savannah, GA 31406
- Louisiana (Baton Rouge): Meridian Clinical Research, 5326 O’Donovan Dr., Baton Rouge, LA 70808
- Maryland (Rockville): Meridian Clinical Research, 1201 Seven Locks Road, Suite 111, Rockville, MD 20854
- Nebraska (Grand Island): Meridian Clinical Research, 2444 West Faidley Avenue, Grand Island, Nebraska 68803
- Nebraska (Norfolk): Meridian Clinical Research, 1410 N 13th St, Suite 5, Norfolk, NE
68701 - Nebraska (Omaha): Meridian Clinical Research, 3319 N 107th St, Omaha, NE 68134
- New York (Binghamton): Meridian Clinical Research, 1290 Upper Front Street, Binghamton, NY 13901
- New York (Endwell): Meridian Clinical Research, 415 Hooper Road, Endwell, NY 13760
- South Dakota (Dakota Dunes): Meridian Clinical Research, 330 Dakota Dunes Blvd., #400, Dakota Dunes, SD 57049
Sponsors and CROs interested in leveraging Meridian’s network for vaccine trials should email Andrew Kimball, VP, business development, at akimball@mcrmed.com.